AKEJF yields 3.12% · JNJ yields 2.13%● Live data
📍 AKEJF pulled ahead of the other in Year 1
Combined, AKEJF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AKEJF + JNJ for your $10,000?
ARIAKE JAPAN Co., Ltd. manufactures, processes, and sells natural seasoning products from chicken, pork, and beef. The company also engages in the production, processing, export/import, and sale of agricultural and livestock products, marine products, quasi-drugs, and non-pharmaceutical products, as well as the management of restaurants. It provides chicken bone base soups, ramen soups, chanpon soups, bouillon and consomme products, sauce bases, and Japanese bouillon products; and livestock meat, including beef, pork, and chicken, as well as shrimps, garlic, and seasoning oils. The company offers its products to instant noodle manufacturing, food service, and food processing industries. It operates in Japan, the United States, China, Taiwan, France, Belgium, the Netherlands, and Indonesia. The company was formerly known as Ariake Tokushu Suisan Hanbai Co., Ltd. and changed its name to ARIAKE JAPAN Co., Ltd. in April 1990. ARIAKE JAPAN Co., Ltd. was founded in 1966 and is headquartered in Tokyo, Japan.
Full AKEJF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.